Your browser doesn't support javascript.
loading
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas.
Rodríguez-Remírez, María; Del Puerto-Nevado, Laura; Fernández-Aceñero, María Jesús; Cruz-Ramos, Marlid; García-García, Laura; Solanes, Sonia; Molina-Roldán, Elena; García-Foncillas, Jesús; Cebrián, Arancha.
Afiliação
  • Rodríguez-Remírez M; Translational Oncology Division, Oncohealth Institute, IIS - Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.
  • Del Puerto-Nevado L; Translational Oncology Division, Oncohealth Institute, IIS - Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.
  • Fernández-Aceñero MJ; Servicio de Anatomía Patológica, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Cruz-Ramos M; Translational Oncology Division, Oncohealth Institute, IIS - Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.
  • García-García L; Translational Oncology Division, Oncohealth Institute, IIS - Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.
  • Solanes S; Translational Oncology Division, Oncohealth Institute, IIS - Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.
  • Molina-Roldán E; Servicio de Anatomía Patológica, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • García-Foncillas J; Translational Oncology Division, Oncohealth Institute, IIS - Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain.
  • Cebrián A; Translational Oncology Division, Oncohealth Institute, IIS - Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain, arancha.cebrian@oncohealth.eu.
Neuroendocrinology ; 111(1-2): 146-157, 2021.
Article em En | MEDLINE | ID: mdl-31991407
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Carcinoma Neuroendócrino / Inibidores da Angiogênese / Receptores de Fatores de Crescimento do Endotélio Vascular / Galectina 1 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Carcinoma Neuroendócrino / Inibidores da Angiogênese / Receptores de Fatores de Crescimento do Endotélio Vascular / Galectina 1 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article